The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.
Open accessAbstract
Two human B-cell differentiation antigens, Bp35 and Bp50, apparently play distinct roles as signal receptors in B-cell activation. Monoclonal antibodies (mAbs) to either Bp35 or Bp50 deliver positive signals to B cells that stimulate their transition through the cell cycle. mAb to Bp35, like anti-immunoglobulin antibodies, functions principally to activate resting B cells to become competent to enter the G1 phase of the cell cycle. In contrast, mAb to Bp50, a 50-kDa polypeptide expressed on all B cells, functions to stimulate activated B cells to traverse the cell cycle. mAb to Bp35, like anti-immunoglobulin antibodies, activates tonsillar B cells and induces low levels of B-cell proliferation. In contrast, anti-Bp50 mAb alone neither activates B cells nor induces B cells to proliferate but, together with anti-Bp35 or anti-immunoglobulin, augments B-cell proliferation. In this respect the action of anti-Bp50 antibody resembles the activity of B-cell growth factor(s) (BCGF). As little as 0.05 microgram of anti-Bp50 per ml is needed to augment proliferation and, like BCGF, anti-Bp50 is effective even when added 12-24 hr after B cells are activated with anti-immunoglobulin or anti-Bp35. Without additional exogenous signals, anti-Bp35 and anti-Bp50 together induce strong proliferation of purified resting B cells. These results suggest that the Bp35 and Bp50 surface molecules function in the regulatory control of B-cell activation and progression through the cell cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*
Ledbetter, J. A., & HERZENBERG, L. A. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00289.x · Cited by 1,914
Self-citationDual control of cell growth by somatomedins and platelet-derived growth factor.
Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, H. N., Van Wyk, J. J., & Pledger, W. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1279 · Cited by 909
Regulation of B-Cell Growth and Differentiation by Soluble Factors
Howard, M., & Paul, W. E. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001515 · Cited by 430
Factors Affecting B-Cell Growth and Differentiation
Kishimoto, T. (1985) · Annual Review of Immunology · doi:10.1146/annurev.iy.03.040185.001025 · Cited by 359
Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco, A. L., Raveche, E. S., Asofsky, R., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1523 · Cited by 293
Growth control of activated, synchronized murine B cells by the C3d fragment of human complement
Melchers, F., Erdei, A., Schulz, T., & Dierich, M. P. (1985) · Nature · doi:10.1038/317264a0 · Cited by 236
Subcompartments of the G1 phase of cell cycle detected by flow cytometry.
Darzynkiewicz, Z., Sharpless, T., Staiano-Coico, L., & Melamed, M. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6696 · Cited by 209
B-cell stimulatory factor 1 activates resting B cells.
Rabin, E. M., Ohara, J., & Paul, W. E. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.9.2935 · Cited by 202
Swain, S. L., Howard, M., Kappler, J., Marrack, P., Watson, J., Booth, R., Wetzel, G. D., & Dutton, R. W. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.822 · Cited by 200
Cited by
Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N., Forveille, M., Dufourcq-Lagelouse, R., Gennery, A., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00079-9 · Cited by 1,647
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Elgueta, R., Benson, M. J., De Vries, V. C., Wasiuk, A., Guo, Y., & Noelle, R. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00782.x · Cited by 1,625
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
Mechanism of antigen-driven selection in germinal centres
Liu, Y.-J., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J., & MacLennan, I. C. M. (1989) · Nature · doi:10.1038/342929a0 · Cited by 1,081
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Self-citationCD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., et al. (1993) · Science · doi:10.1126/science.7679801 · Cited by 830
Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90668-g · Cited by 814
Self-citationHow B and T cells talk to each other
Clark, E. A., & Ledbetter, J. A. (1994) · Nature · doi:10.1038/367425a0 · Cited by 641
Self-citationDefrance, T., Vanbervliet, B., Brière, F., Durand, I., Rousset, F., & Banchereau, J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.671 · Cited by 638
Ranheim, E. A., & Kipps, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.925 · Cited by 580
Sanz, I., Wei, C., Jenks, S. A., Cashman, K. S., Tipton, C., Woodruff, M. C., Hom, J., & Lee, F. E.-H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02458 · Cited by 569
Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2309-2318.1990 · Cited by 566
A brief history of T cell help to B cells
Crotty, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3803 · Cited by 553
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E., & Rousset, F. (1991) · Science · doi:10.1126/science.1702555 · Cited by 533
Stamenkovic, I., Clark, E. A., & Seed, B. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03521.x · Cited by 515
Self-citationHollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05530.x · Cited by 511
Self-citationKarmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., & Pober, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4342 · Cited by 472
Involvement of CRAF1, a relative of TRAF, in CD40 signaling
Cheng, G., Cleary, A. M., Ye, Z.-S., Hong, D. I., Lederman, S., & Baltimore, D. (1995) · Science · doi:10.1126/science.7533327 · Cited by 449
The role of CD40 and CD154/CD40L in dendritic cells
Ma, D. Y., & Clark, E. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.010 · Cited by 446
“Our initial studies emphasized that CD40 was expressed on B cells and that ligating CD40 induced B cells to proliferate [1,2].”
Self-citationExpression of functional CD40 by vascular endothelial cells.
Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., & Aruffo, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.33 · Cited by 411
The SCID but Not the RAG-2 Gene Product Is Required for Sμ–Sε Heavy Chain Class Switching
Rolink, A., Melchers, F., & Andersson, J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80258-7 · Cited by 405
B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
Tsubata, T., Wu, J., & Honjo, T. (1993) · Nature · doi:10.1038/364645a0 · Cited by 381
Mallett, S., Fossum, S., & Barclay, A. N. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08211.x · Cited by 379
Foy, T. M., Shepherd, D. M., Durie, F. H., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1567 · Cited by 348
Self-citationTargeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.005 · Cited by 334
Lane, P., Traunecker, A., Hubele, S., Inui, S., Lanzavecchia, A., & Gray, D. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221016 · Cited by 313
CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
Van Kooten, C., & Banchereau, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60865-2 · Cited by 311
Boyd, A. W., Wawryk, S. O., Burns, G. F., & Fecondo, J. V. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3095 · Cited by 309
Interleukin 13 is a B cell stimulating factor.
Defrance, T., Carayon, P., Billian, G., Guillemot, J. C., Minty, A., Caput, D., & Ferrara, P. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.135 · Cited by 294
Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease
Rickert, R. C., Jellusova, J., & Miletic, A. V. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01067.x · Cited by 285
Grell, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3034 · Cited by 284
Einfeld, D. A., Brown, J. P., Valentine, M. A., Clark, E. A., & Ledbetter, J. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02867.x · Cited by 278
Self-citationFunctional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D., & Chess, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1857 · Cited by 273
Immunoglobulin V H 3 Gene Products: Natural Ligands for HIV gp120
Berberian, L., Goodglick, L., Kipps, T. J., & Braun, J. (1993) · Science · doi:10.1126/science.7690497 · Cited by 263
Metadata
- Authors
- Clark, E. A., & Ledbetter, J. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-06
- Volume
- 83
- Issue
- 12
- Pages
- 4494-4498
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2050432242
- Cited by
- 429
- References
- 21
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.